Ryan Specialty Group (RYAN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Feb, 2026Executive summary
Achieved $3.1 billion in total revenue for 2025, representing 21.3% year-over-year growth with 10.1% organic growth and significant M&A contributions.
Fifteenth consecutive year of double-digit organic revenue growth, maintaining leading positions as the 2nd largest U.S. P&C wholesale broker and largest delegated underwriter by premium volume.
Launched Project Empower, a three-year restructuring program targeting $80 million in annual savings by 2029, with $160 million in one-time charges through 2028.
Authorized a $300 million share repurchase program and increased the regular quarterly dividend by 8% to $0.13 per share.
Completed five acquisitions in 2025, expected to add over $125 million in annualized revenue.
Financial highlights
Revenue grew from $2.52 billion in 2024 to $3.05 billion in 2025; Q4 2025 revenue was $751.2 million, up 13.2% year-over-year with 6.6% organic growth.
Full-year adjusted EBITDAC rose 19.2% to $967 million, with a margin of 31.7%; Adjusted Diluted EPS increased 9.5% to $1.96.
Net income for 2025 was $214 million, with Q4 net income down 26.6% year-over-year to $31.2 million due to higher expenses.
Adjusted net income for 2025 rose 11.1% to $548.2 million; Q4 adjusted EBITDAC margin declined to 29.6% from 32.6%.
Adjusted effective tax rate was 26% for both Q4 and full year.
Outlook and guidance
2026 organic revenue growth rate is guided to be in the high single digits, with Q1 expected to be the strongest quarter.
Adjusted EBITDAC margin for 2026 is expected to be flat to moderately down versus 2025, due to lower interest income and higher benefit costs.
Project Empower is expected to deliver $80 million in annual savings by 2029, with $160 million in cumulative special charges through 2028.
Positioned for continued growth through organic expansion, strategic acquisitions, and new product launches.
Ample M&A opportunities in a fragmented U.S. and international market, with panel consolidation expected to accelerate growth.
Latest events from Ryan Specialty Group
- Record revenue, expanded shareholder rights, and a focus on performance-based leadership mark 2025.RYAN
Proxy Filing17 Mar 2026 - Shareholders will vote on director elections, auditor ratification, and executive pay approval.RYAN
Proxy Filing17 Mar 2026 - Q2 revenue up 23% to $855.2M, net income up 5.6%, guidance lowered amid property headwinds.RYAN
Q2 202512 Feb 2026 - Q3 revenue up 25% and net income up 118.6%, with strong organic growth and margin pressures from investments.RYAN
Q3 202512 Feb 2026 - Double-digit growth and E&S market leadership driven by complexity, scale, and innovation.RYAN
Investor presentation12 Feb 2026 - Revenue up 18.8%, net income up 40.8%, with margin and guidance both raised.RYAN
Q2 20242 Feb 2026 - Double-digit growth and margin expansion are fueled by E&S specialization, M&A, and innovation.RYAN
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Strategic acquisitions, leadership continuity, and E&S market growth drive future expansion.RYAN
2024 KBW Insurance Conference22 Jan 2026 - Q3 revenue up 20.5%, net income up 82.4%, and adjusted EBITDA up 29.4% year-over-year.RYAN
Q3 202417 Jan 2026